Technical Analysis for ANIX - Anixa Biosciences, Inc.

Grade Last Price % Change Price Change
D 4.65 3.33% 0.15
ANIX closed up 3.33 percent on Monday, April 12, 2021, on 69 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical ANIX trend table...

Date Alert Name Type % Chg
Lizard Bullish Bullish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Doji - Bullish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 3.33%
Narrow Range Bar Range Contraction 3.33%
NR7 Range Contraction 3.33%
NR7-2 Range Contraction 3.33%
Older End-of-Day Signals for ANIX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 8 hours ago
60 Minute Opening Range Breakout about 8 hours ago
Rose Above 10 DMA about 8 hours ago
Rose Above Previous Day's High about 12 hours ago
10 DMA Resistance about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Anixa, a cancer-focused biotechnology company, is harnessing the body's immune system in the fight against cancer. Anixa is developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. Anixa also continually examines emerging technologies in complementary or related fields for further development and commercialization.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Emerging Technologies Cancer Treatments Gene Therapy Leukemia Amines Blood Test Immune Response Blood Tests Chimeric Antigen Receptor

Is ANIX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.09
52 Week Low 1.7
Average Volume 668,211
200-Day Moving Average 3.30
50-Day Moving Average 5.06
20-Day Moving Average 5.28
10-Day Moving Average 4.67
Average True Range 0.52
ADX 14.5
+DI 18.78
-DI 22.47
Chandelier Exit (Long, 3 ATRs ) 6.52
Chandelier Exit (Short, 3 ATRs ) 5.78
Upper Bollinger Band 7.17
Lower Bollinger Band 3.38
Percent B (%b) 0.33
BandWidth 71.82
MACD Line -0.18
MACD Signal Line -0.09
MACD Histogram -0.0904
Fundamentals Value
Market Cap 110.62 Million
Num Shares 23.8 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -6.07
Price-to-Sales 152.51
Price-to-Book 6.29
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.23
Resistance 3 (R3) 5.20 4.96 5.14
Resistance 2 (R2) 4.96 4.81 4.98 5.10
Resistance 1 (R1) 4.81 4.72 4.88 4.84 5.07
Pivot Point 4.57 4.57 4.61 4.59 4.57
Support 1 (S1) 4.42 4.42 4.50 4.46 4.23
Support 2 (S2) 4.18 4.33 4.20 4.20
Support 3 (S3) 4.03 4.18 4.16
Support 4 (S4) 4.07